Advanced search
1 file | 3.83 MB Add to list

Kinetic analysis of [18F] altanserin bolus injection in the canine brain using PET imaging

Author
Organization
Abstract
Background: Currently, [F-18] altanserin is the most frequently used PET-radioligand for serotonin(2A) (5-HT2A) receptor imaging in the human brain but has never been validated in dogs. In vivo imaging of this receptor in the canine brain could improve diagnosis and therapy of several behavioural disorders in dogs. Furthermore, since dogs are considered as a valuable animal model for human psychiatric disorders, the ability to image this receptor in dogs could help to increase our understanding of the pathophysiology of these diseases. Therefore, five healthy laboratory beagles underwent a 90-min dynamic PET scan with arterial blood sampling after [F-18] altanserin bolus injection. Compartmental modelling using metabolite corrected arterial input functions was compared with reference tissue modelling with the cerebellum as reference region. Results: The distribution of [F-18] altanserin in the canine brain corresponded well to the distribution of 5-HT2A receptors in human and rodent studies. The kinetics could be best described by a 2-Tissue compartment (2-TC) model. All reference tissue models were highly correlated with the 2-TC model, indicating compartmental modelling can be replaced by reference tissue models to avoid arterial blood sampling. Conclusions: This study demonstrates that [F-18] altanserin PET is a reliable tool to visualize and quantify the 5-HT2A receptor in the canine brain.
Keywords
Canine brain, Kinetic modelling, 5HT2a receptor, Mood-disorders, SEROTONIN 2A RECEPTOR, IN-VIVO, 5-HT2A RECEPTORS, ANIMAL-MODELS, BINDING, QUANTIFICATION, TRANSPORTER, METABOLITES, VALIDATION, DISORDER

Downloads

  • s12917-019-2165-5.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 3.83 MB

Citation

Please use this url to cite or link to this publication:

MLA
Pauwelyn, Glenn, et al. “Kinetic Analysis of [18F] Altanserin Bolus Injection in the Canine Brain Using PET Imaging.” BMC VETERINARY RESEARCH, vol. 15, 2019, doi:10.1186/s12917-019-2165-5.
APA
Pauwelyn, G., Vlerick, L., Dockx, R., Verhoeven, J., Dobbeleir, A., Bosmans, T., … De Vos, F. (2019). Kinetic analysis of [18F] altanserin bolus injection in the canine brain using PET imaging. BMC VETERINARY RESEARCH, 15. https://doi.org/10.1186/s12917-019-2165-5
Chicago author-date
Pauwelyn, Glenn, Lise Vlerick, Robrecht Dockx, Jeroen Verhoeven, André Dobbeleir, Tim Bosmans, Kathelijne Peremans, Christian Vanhove, Ingeborgh Polis, and Filip De Vos. 2019. “Kinetic Analysis of [18F] Altanserin Bolus Injection in the Canine Brain Using PET Imaging.” BMC VETERINARY RESEARCH 15. https://doi.org/10.1186/s12917-019-2165-5.
Chicago author-date (all authors)
Pauwelyn, Glenn, Lise Vlerick, Robrecht Dockx, Jeroen Verhoeven, André Dobbeleir, Tim Bosmans, Kathelijne Peremans, Christian Vanhove, Ingeborgh Polis, and Filip De Vos. 2019. “Kinetic Analysis of [18F] Altanserin Bolus Injection in the Canine Brain Using PET Imaging.” BMC VETERINARY RESEARCH 15. doi:10.1186/s12917-019-2165-5.
Vancouver
1.
Pauwelyn G, Vlerick L, Dockx R, Verhoeven J, Dobbeleir A, Bosmans T, et al. Kinetic analysis of [18F] altanserin bolus injection in the canine brain using PET imaging. BMC VETERINARY RESEARCH. 2019;15.
IEEE
[1]
G. Pauwelyn et al., “Kinetic analysis of [18F] altanserin bolus injection in the canine brain using PET imaging,” BMC VETERINARY RESEARCH, vol. 15, 2019.
@article{8637970,
  abstract     = {{Background: Currently, [F-18] altanserin is the most frequently used PET-radioligand for serotonin(2A) (5-HT2A) receptor imaging in the human brain but has never been validated in dogs. In vivo imaging of this receptor in the canine brain could improve diagnosis and therapy of several behavioural disorders in dogs. Furthermore, since dogs are considered as a valuable animal model for human psychiatric disorders, the ability to image this receptor in dogs could help to increase our understanding of the pathophysiology of these diseases. Therefore, five healthy laboratory beagles underwent a 90-min dynamic PET scan with arterial blood sampling after [F-18] altanserin bolus injection. Compartmental modelling using metabolite corrected arterial input functions was compared with reference tissue modelling with the cerebellum as reference region.
Results: The distribution of [F-18] altanserin in the canine brain corresponded well to the distribution of 5-HT2A receptors in human and rodent studies. The kinetics could be best described by a 2-Tissue compartment (2-TC) model. All reference tissue models were highly correlated with the 2-TC model, indicating compartmental modelling can be replaced by reference tissue models to avoid arterial blood sampling.
Conclusions: This study demonstrates that [F-18] altanserin PET is a reliable tool to visualize and quantify the 5-HT2A receptor in the canine brain.}},
  articleno    = {{415}},
  author       = {{Pauwelyn, Glenn and Vlerick, Lise and Dockx, Robrecht and Verhoeven, Jeroen and Dobbeleir, André and Bosmans, Tim and Peremans, Kathelijne and Vanhove, Christian and Polis, Ingeborgh and De Vos, Filip}},
  issn         = {{1746-6148}},
  journal      = {{BMC VETERINARY RESEARCH}},
  keywords     = {{Canine brain,Kinetic modelling,5HT2a receptor,Mood-disorders,SEROTONIN 2A RECEPTOR,IN-VIVO,5-HT2A RECEPTORS,ANIMAL-MODELS,BINDING,QUANTIFICATION,TRANSPORTER,METABOLITES,VALIDATION,DISORDER}},
  language     = {{eng}},
  pages        = {{11}},
  title        = {{Kinetic analysis of [18F] altanserin bolus injection in the canine brain using PET imaging}},
  url          = {{http://dx.doi.org/10.1186/s12917-019-2165-5}},
  volume       = {{15}},
  year         = {{2019}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: